Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

tACS for Working Memory in Schizophrenia

NCT: NCT07701343 · RECRUITING

NCT IDNCT07701343
StatusRECRUITING
Start Date2026-07-06
Completion2026-12-31
SponsorCentral South University (OTHER)
First posted
Last updated

Brief Summary

This study is a randomized, single-blind, sham-controlled crossover trial enrolling 30 schizophrenia patients, each receiving one active and one sham tACS session (7-day washout), targeting P3/P4 at individual alpha frequency (2mA, 30min) during a working memory task, with accuracy and reaction time as primary outcomes, alongside EEG and neurophysiological measures, to test the efficacy and mechanisms of individualized alpha-tACS on working memory.

Frequently Asked Questions

What is tACS for Working Memory in Schizophrenia?

tACS for Working Memory in Schizophrenia is a clinical trial registered under NCT07701343. Current status: RECRUITING.

What is the status of NCT07701343?

The current status of NCT07701343 (tACS for Working Memory in Schizophrenia) is: RECRUITING.

When did tACS for Working Memory in Schizophrenia start?

tACS for Working Memory in Schizophrenia started on 2026-07-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.